These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Preventing HIV transmission in "priority" countries. Finger WR Netw Res Triangle Park N C; 1993 May; 13(4):18-21. PubMed ID: 12344871 [TBL] [Abstract][Full Text] [Related]
45. Food security and emerging infectious disease: risk assessment and risk management. Trivellone V; Hoberg EP; Boeger WA; Brooks DR R Soc Open Sci; 2022 Feb; 9(2):211687. PubMed ID: 35223062 [TBL] [Abstract][Full Text] [Related]
46. Scientific Collaborations: How Do We Measure the Return on Relationships? Fair JM; Stokes MM; Pennington D; Mendenhall IH Front Public Health; 2016; 4():9. PubMed ID: 26913278 [TBL] [Abstract][Full Text] [Related]
47. Review of Emerging Infectious Disease Preparedness Measures for the State of Delaware. Kupferman N; Hanlin E Dela J Public Health; 2019 Oct; 5(4):64-67. PubMed ID: 34467060 [TBL] [Abstract][Full Text] [Related]
48. Emerging and Re-emerging Infectious Diseases: Public Health Perspective. Shrivastava SR; Shrivastava PS; Ramasamy J Int J Prev Med; 2013 Jun; 4(6):736-7. PubMed ID: 23930196 [No Abstract] [Full Text] [Related]
49. The challenge of infectious diseases: the European perspective. Vandenbroucke-Grauls CM; Griffin GE; van Der Meer JW Clin Microbiol Infect; 1997 Aug; 3(4):511-512. PubMed ID: 11864172 [No Abstract] [Full Text] [Related]
50. Emerging Infectious Diseases. McArthur DB Nurs Clin North Am; 2019 Jun; 54(2):297-311. PubMed ID: 31027668 [TBL] [Abstract][Full Text] [Related]
51. Factors in the emergence of infectious diseases. Morse SS Emerg Infect Dis; 1995; 1(1):7-15. PubMed ID: 8903148 [TBL] [Abstract][Full Text] [Related]
52. How do host population dynamics impact Lyme disease risk dynamics in theoretical models? Savage JDT; Moore CM PLoS One; 2024; 19(5):e0302874. PubMed ID: 38722910 [TBL] [Abstract][Full Text] [Related]
53. Comparison of neutralization potency across passive immunotherapy approaches as potential treatments for emerging infectious diseases. Ranjbaran H; Ehteshaminia Y; Nadernezhad M; Jalali SF; Jadidi-Niaragh F; Pagheh AS; Enderami SE; Kenari SA; Hassannia H Heliyon; 2024 Jan; 10(1):e23478. PubMed ID: 38226283 [TBL] [Abstract][Full Text] [Related]
54. A scoping review on laboratory surveillance in the WHO Southeast Asia Region: Past, present and the future. Goel V; Mathew S; Gudi N; Jacob A; John O J Glob Health; 2023 Apr; 13():04028. PubMed ID: 37083001 [TBL] [Abstract][Full Text] [Related]
55. Antibacterial and Antibiofilm Activities of β-Lapachone by Modulating the Catalase Enzyme. Mir MA; Altuhami SA; Mondal S; Bashir N; Dera AA; Alfhili MA Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978443 [TBL] [Abstract][Full Text] [Related]
56. Designing an optimization model for the vaccine supply chain during the COVID-19 pandemic. Valizadeh J; Boloukifar S; Soltani S; Jabalbarezi Hookerd E; Fouladi F; Andreevna Rushchtc A; Du B; Shen J Expert Syst Appl; 2023 Mar; 214():119009. PubMed ID: 36312907 [TBL] [Abstract][Full Text] [Related]
58. Developing an In-House Biological Safety Cabinet Certification Program at the University of North Dakota. Ghosh S; Voigt J; Wynne T; Nelson T Appl Biosaf; 2019 Sep; 24(3):153-160. PubMed ID: 36032333 [TBL] [Abstract][Full Text] [Related]
59. Synthesis, Biological Evaluation and Molecular Docking Studies of 5-Indolylmethylen-4-oxo-2-thioxothiazolidine Derivatives. Horishny V; Geronikaki A; Kartsev V; Matiychuk V; Petrou A; Pogodin P; Poroikov V; Papadopoulou TA; Vizirianakis IS; Kostic M; Ivanov M; Sokovic M Molecules; 2022 Feb; 27(3):. PubMed ID: 35164333 [TBL] [Abstract][Full Text] [Related]